← Back to ARQT

Arcutis Biotherapeutics, Inc. - Common stock financial statements

Annual and standalone quarterly facts filed by the company with the SEC. Monetary values are shown in USD millions; per-share values use USD.

Filed statements

USD; millions except EPSJun 2026Filed 05/08/2026Mar 2026Filed 05/08/2026Sep 2025Filed 28/10/2025Jun 2025Filed 05/08/2026Mar 2025Filed 05/08/2026Sep 2024Filed 28/10/2025Jun 2024Filed 28/10/2025Mar 2024Filed 28/10/2025
$130$105$99$82$64$45$31$22
$15−$11$7.4−$16−$25−$42−$52−$35
$0.11−$0.09$0.06−$0.13−$0.20−$0.33−$0.42−$0.32
136133127124123111

Trend

Revenue

Source: SEC EDGAR Company Facts. Values are normalized from issuer-filed US GAAP or IFRS XBRL facts. Missing cells stay missing; cumulative interim cash flows are not converted into estimated quarters.